Rest and the restless: In stem cells and beyond

Future Neurology

Volumn 4, Issue 3, 2009, Pages 317-329

  Gopalakrishnan, Vidya ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Down's syndrome; Embryonic stem cells; Medulloblastoma; Neural stem cells; Neuronal differentiation; Non neural stem cells; Oncogenic activity; Pluripotency; Regulation of self renewal; REST NRSF; Tumor suppressor activity

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; CELL PROTEIN; COCAINE AND AMPHETAMINE REGULATED TRANSCRIPT PEPTIDE; LIM KINASE; MICRORNA; REPRESSOR ELEMENT 1 SILENCING TRANSCRIPTION FACTOR; REPRESSOR PROTEIN; TELOMERIC REPEAT BINDING FACTOR 2; TRYPTOPHAN HYDROXYLASE 2; UBIQUITIN THIOLESTERASE; UNCLASSIFIED DRUG;

BINDING SITE; CARCINOGENESIS; CELL FATE; CELL RENEWAL; CELL SPECIFICITY; EMBRYONIC STEM CELL; FIBROBLAST; GENE ACTIVITY; GENE EXPRESSION; GENE FUNCTION; GENE IDENTIFICATION; GENE REPRESSION; GENETIC ASSOCIATION; HUMAN; NERVE CELL PLASTICITY; NEURAL STEM CELL; NEUROLOGIC DISEASE; NONHUMAN; ONCOGENE; PLURIPOTENT STEM CELL; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR GENE; X LINKED MENTAL RETARDATION;

EID: 67149121885     PISSN: 14796708     EISSN: None     Source Type: Journal    
DOI: 10.2217/fnl.09.1     Document Type: Review

References (94)

1. Chong JA, Tapia-RamiRez J, Kim S et al.: REST: a mammalian silencer protein that restricts sodium channel gene expression to neurons. Cell 80, 949-957 (1995).
2. Schoenherr CJ, Anderson DJ: The neuron-restrictive silencer factor (NRSF): a coordinate represser of multiple neuron-specific genes. Science 267, 1360-1363 (1995).
3. Chen ZF, Paquette AJ, Anderson DJ: NRSF/REST is required in vivo for repression of multiple neuronal target genes during embryogenesis. Nat. Genet. 20, 136-142 (1998).
4. Roopra A, Huang Y, Dingledine R: Neurological disease: listening to gene silencers. Mol. Interv. 1, 219-228 (2001).
5. Ballas N, Mandel G: The many faces of REST oversee epigenetic programming of neuronal genes. Curr. Opin. Neurobiol. 15, 500-506 (2005).
6. Coulson JM: Transcriptional regulation: cancer, neurons and the REST. Curr. Biol. 15, R665-R668 (2005).
7. Hsieh J, Gage FH: Chromatin remodeling in neural development and plasticity. Curr. Opin. Cell. Biol. 17, 1-8 (2005).
8. Lunyak VV, Rosenfeld MG: No rest for REST: REST/NRSF regulation of neurogenesis. Cell 121, 499-501 (2005).
9. Majumder S: REST in good times and bad: roles in tumor suppressor and oncogenic activities. Cell Cycle 5, 1929-1935 (2006).
10. Cao X, Yeo G, Muotri AR et al.: Noncoding RNAs in the mammalian central nervous system. Annu. Rev. Neurosci. 29, 77-103 (2006).
11. Ooi L, Wood IC: Chromatin crosstalk in development and disease: lessons from REST. Nat. Rev. Genet. 8, 544-554 (2007).
12. Weissman A: How much REST is enough? Cancer Cell 13, 381-383 (2008).
13. Ooi L, Wood IC: Regulation of gene expression in the nervous system. Biochem. J. 414, 327-341 (2008).
14. Hermanson O: Stem Cells have different needs for REST. PLoS Biol. 6, 2094-2097 (2008).
15. Kraner SD, Chong JA, Tsay HJ, Mandel G: Silencing the type II sodium channel gene: a model for neural-specific gene regulation. Neuron 9, 37-44 (1992).
16. Bruce AW, Donaldson IJ, Wood IC et al.: Genome-wide analysis of repressor element 1 silencing transcription factor/neuron-restrictive silencing factor (REST/NRSF) target genes. Proc. Natl Acad. Sci. USA 101, 10458-10463 (2004).
17. Johnson R, Gamblin RJ, Ooi L et al.: Identification of REST regulon reveals extensive transposable element-mediated binding site duplication. Nucleic Acids Res. 34, 3862-3877 (2006).
18. Otto SJ, McCorkle SR, Hover J et al.: A new binding motif for the transcriptional repressor REST uncovers large gene networks devoted to neuronal functions. J. Neurosci. 27, 6729-6739 (2007).
19. Johnson DS, Mortazavi A, Myers RM et al.: Genome-wide mapping of in vivo protein DNA interactions. Science 316, 1497-1502 (2007).
20. Conaco C, Otto S, Han JJ et al.: Reciprocal actions of REST and a microRNA promote neuronal identity. Proc. Natl Acad. Sci. USA 103, 2422-2427 (2006).
21. Visvanathan J, Le S, Le B et al.: The microRNA miR-124 antagonizes the anti-neural REST/SCP1 pathway during embryonic CNS development. Genes Dev. 21, 744-749 (2006).
22. Wu J and Xie X: Comparative sequence analysis reveals an intricate network among REST, CREB and miRNA in mediating neuronal gene expression. Genome Biol. 7, R85 (2007).
23. Mortazavi A, Leeper Thompson EC et al.: Comparative genomics modeling of the NRSF/REST network: from single conserved sites to genome-wide repertoire. Genome Res. 16, 1208-1221 (2006).
24. Jothi R, Cuddapah S, Barski A et al.: Genome-wide identification of in vivo protein DNA binding sites from ChIP-Seq data. Nucleic Acids Res. 36, 5221-5231 (2008).
25. Sun YM, Greenway DJ, Johnson R et al.: Distinct profiles of REST interaction with its target genes at different stages of neuronal development. Mol. Cell. Biol. 16, 5630-5638 (2005).
26. Greenway DJ, Street M, Jeffries A, Buckley NJ: RE1 silencing transcription factor maintains a repressive chromatin environment in embryonic hippocampal neural stem cells. Stem Cells 25, 354-363 (2007).
27. Johnson R, Teh CH-L, Kunarso G et al.: REST regulates distinct transcriptional networks in embryonic and neural stem cells. PLoS Biol. 6, 2205-2219 (2008).
28. Sun YM, Cooper M, Finch S et al.: REST-mediated regulation of extracellular matrix is crucial for neural development. PLoS ONE 3, E3656 (2008).
29. Johnson R, Teh CH, Jia H et al.: Regulation of neural macroRNAs by the transcriptional repressor REST. RNA 15, 85-96 (2009).
30. Zuccato C, Tartari M, Crotti A et al.: Huntingtin interacts with REST/NRSF to modulate the transcription of NRSE-controlled neuronal genes. Nat. Genet. 35, 76-83 (2003).
31. Zuccato C, Belyaev N, Conforti P et al.: Widespread disruption of repressor element-1 silencing transcription factor/neuron restrictive silencer factor occupancy at its target genes in Huntington's disease. J. Neurosci. 27, 6972-6983 (2007).
32. Johnson R, Zuccato C, Belyaev ND et al.: A microRNA-based gene dysregulation pathway in Huntington's disease. Neurobiol. Dis. 29, 438-445 (2008).
33. Qiang M, Rani CS, Ticku MK: Neuron-restrictive silencer factor regulates the N-methyl-D-aspartate receptor 2B subunit gene in basal and ethanol-induced gene expression in fetal cortical neurons. Mol. Pharmacol. 67, 2115-2125 (2005).
34. Cheong A, Bingham AJ, Li J et al.: Downregulated REST transcription factor is a switch enabling critical potassium channel expression and cell proliferation. Mol. Cell 20, 45-52 (2005).
35. Ohba T, Watanabe H, Takahashi Y et al.: Regulatory role of neuron-restrictive silencing factor in the expression of TRPC1. Biochem. Biophys. Res. Commun. 351, 764-770 (2006).
36. Nakagawa Y, Kuwahara K, Harada M et al.: Class II HDACs mediate CaMK-dependent signaling to NRSF in ventricular myocytes. J. Mol. Cell. Cardiol. 41, 1010-1022 (2006).
37. Kuratomi S, Kuratomi A, Kuwahara K et al.: NRSF regulates the developmental and hypertrophic changes of HCN4 transcription in rat cardiac myocytes. Biochem. Biophys. Res. Commun. 353, 67-73 (2007).
38. Ding N, Tommori-Sato C, Sato S et al.: MED19 and MED26 are synergistic functional targets of the RE1 silencing transcription factor in epigenetic silencing of neuronal gene expression. J. Biol. Chem. 284, 2648-2656 (2009).
39. Calderone A, Jover T, Noh KM et al.: Ischemic insults derepress the gene silencer REST in neurons destined to die. J. Neurosci. 23, 2112-2121 (2003).
40. Garriga-Canut M, Scoenike B, Qazi R et al.: 2-deoxy- D-glucose reduces epilepsy progression by NRSF-CtBP-dependent metabolic regulation of chromatin structure. Nat. Neurosci. 9, 1382-1387 (2006).
41. Formisano L, Noh KM, Miyawaki T et al.: Ischemic insults promote epigenetic reprogramming of μ opioid receptor expression in hippocampal neurons. Proc. Natl Acad. Sci. USA 104, 4170-4175 (2007).
42. Tateno M, Ukai W, Hashimoto E et al.: Implication of increased NRSF/REST binding activity in the mechanism of ethanol inhibition of neuronal differentiation. J. Neural Transm. 113, 283-293 (2006).
43. Ishii T, Hashimoto E, Ukai W et al.: Lithium induced suppression of transcription factor NRSF/REST: effects on the dysfunction of neuronal differentiation by ethanol. Eur. J. Pharmacol. 593, 36-43 (2008).
44. Patel PD, Bochar DA, Turner DL et al.: Regulation of tryptophan hydroxylase-2 gene expression by a bi-partite RE-1 silencer of transcription/neuron restrictive silencing factor (REST/NRSF) binding motif. J. Biol. Chem. 282, 26717-26724 (2007).
45. Li Y, Liu Q, Yang Y et al.: Regulatory role of neuron-restrictive silencing factor in the specific expression of cocaine- and amphetamine-regulated transcript gene. J. Neurochem. 106, 1314-1324 (2008).
46. Barrachina M, Moreno J, Juves S, Moreno D, Olive M, Ferrer I: Targets of neuron-restrictive silencing factor are abnormally up-regulated in human myotilinopathy. Am. J. Pathol. 171, 1312-1323 (2007).
47. Lee MG, Wynder C, Cooch N et al.: An essential role for CoREST in nucleosomal histone 3 lysine 4 demethylation. Nature 437, 432-435 (2005).
48. Yeo M, Lee SK, Lee B et al.: Small CTD phosphatases function in silencing neuronal gene expression. Science 307, 596-600 (2005).
49. Watanabe H, Mizutani T, Haraguchi T et al.: SWI/SNF complex is essential for NRSF-mediated suppression of neuronal genes in human nonsmall cell lung carcinoma cell lines. Oncogene 25, 470-479 (2006).
50. Iwase S, Lan F, Bayliss P et al.: The X-linked mental retardation gene SMCX/JARID1 defines a family of histone H3 lysine 4 demethylases. Cell 128, 1077-1088 (2007).
51. Tahiliani M, Mei P, Fang R et al.: The histone H3K4 demethylase SMCX links REST target genes to X-linked mental retardation. Nature 447, 601-605 (2007).
52. Ding N, Zhou H, Esteve PO et al.: Mediator links epigenetic silencing of neuronal gene expression with X-linked mental retardation. Mol. Cell 3, 347-359 (2008).
53. Mulligan P, Westbrook TF, Ottinger M et al.: CDYL bridges REST and histone methyltransferases for gene repression and suppression of cellular transformation. Mol. Cell 32, 718-726 (2008).
54. Zhang P, Pazin M, Schwartz CM et al.: Non-telomeric TRF2-REST interaction modulates neuronal gene silencing and fate of tumor and stem cells. Curr. Biol. 18, 1489-1494 (2008).
55. Bassuk AG, Wallace RH, Buhr A et al.: A homozygous mutation in PRICKLE1 causes an autosomal-recessive progressive myoclonus epilepsy - ataxia syndrome. Am. J. Hum. Genet. 83, 572-581 (2008).
56. Shimojo M, Hersh LB: REST/NRSF-interacting LIM domain protein, a putative nuclear translocation receptor. Mol. Cell. Biol. 23, 9025-9031 (2003).
57. Shimojo M: Huntingtin regulates repressor element-1 silencing transcription factor (REST/NRSF) nuclear trafficking indirectly through a complex with REST/NRSF-interacting LIM domain interacting protein (RILP) and dynactin p150Glued. J. Biol. Chem. 283, 34880-34886 (2008).
58. Willert J, Epping M, Pollack R et al.: A transcriptional response to Wnt protein in human embryonic carcinoma cells. BMC Dev. Biol. 2, 8-15 (2002).
59. Nishihara S, Tsuda L, Ogura T: The canonical Wnt pathway directly regulates NRSF/REST expression in chick spinal cord. Biochem. Biophys. Res. Commun. 311, 55-63 (2003).
60. Ballas N, Grunseich C, Lu D et al.: REST and its corepressors mediate plasticity of neuronal gene chromatin throughout neurogenesis. Cell 121, 645-657 (2005).
61. Westbrook TF, Hu G, Ang XL et al.: SCFβ-TRCP controls oncogenic transformation and neural differentiation through REST degradation. Nature 452, 370-374 (2008).
62. Kuwabara T, Hsieh J, Nakashima K et al.: A small modulatory dsRNA specifies the fate of adult neural stem cells. Cell 116, 779-793 (2004).
63. Abramovitz L, Shapira T, Ben-Dror I et al.: Dual role of NRSF/REST in activation and repression of the glucocorticoid response. J. Biol. Chem. 283, 110-119 (2008).
64. Guardavaccaro D, Frescas D, Dorrello NV et al.: Control of chromosome stability by the β-TrCP-REST-Mad2 axis. Nature 452, 365-369 (2008).
65. Westbrook TF, Martin ES, Schlabach MR et al.: A genetic screen for candidate tumor suppressors identifies REST. Cell 121, 837-848 (2005).
66. Lawinger P, Venugopal R, Guo ZS et al.: The neuronal repressor REST/NRSF is an essential regulator in medulloblastoma cells. Nat. Med. 6, 826-831 (2000).
67. Fuller GN, Su X, Price RE et al.: Many human medulloblastoma tumors overexpress repressor element-1 silencing transcription (REST)/ neuron-restrictive silencer factor (NRSF), which can be functionally countered by REST-VP16. Mol. J. Cancer Ther. 4, 343-349 (2005).
68. Su X, Gopalakrishnan V, Stearns D et al.: Abnormal expression of REST/NRSF and Myc in neural stem/progeniror cells causes cerebellar tumors by blocking neuronal differentiation. Mol. Cell. Biol. 26, 1666-1678 (2006).
69. Paquette AJ, Perez SE, Anderson DJ: Constitutive expression of the neuron-restrictive silencer factor (NRSF)/REST in differentiating neurons disrupts neuronal gene expression and causes axon pathfinding errors in vivo. Proc. Natl Acad. Sci. USA 97, 12318-12323 (2000).
70. Fogarty MP, Kessler JD, Wechsler-Reya RJ: Morphing into cancer: the role of developmental signaling pathways in brain tumor formation. J. Neurobiol. 64, 458-475 (2005).
71. Ferretti E, De Smaele E, Po A et al.: MicroRNA profiling in human medulloblastoma Int. J. Cancer 124, 568-577 (2009)
72. Immaneni A, Lawinger P, Zhao Z et al.: REST-VP16 activates multiple neuronal differentiation genes in human NT2 cells. Nucleic Acids Res. 28, 3403-3410 (2000).
73. Su X, Kameoka S, Lentz S et al.: Activation of REST/NRSF target genes in neural stem cells is sufficient to cause neuronal differentiation. Mol. Cell. Biol. 24, 8018-8025 (2004).
74. Watanabe Y, Kameoka S, Gopalakrishnan V et al.: Conversion of myoblasts to physiologically active neuronal phenotype. Genes Dev. 18, 889-900 (2004).
75. Shi Y, Desponts C, Do JT et al.: Induction of pluripotent stem cells from mouse embryonic fibroblasts by Oct4 and Klf4 with small-molecule compounds. Cell Stem Cell 3, 568-574 (2008).
76. Nishikawa S, Goldstein RA, Nierras CR et al.: The promise of human induced pluripotent stem cells for research and therapy. Nat. Rev. Mol. Cell. Biol. 9, 725-729 (2008).
77. Huangfu D, Osafune K, Maehr R et al.: Induction of pluripotent stem cells from primary human fibroblasts. Nat. Biotech. 26, 1269-1275 (2008).
78. Wang J, Rao S, Chu J et al.: A protein interaction network for pluripotency of embryonic stem cells. Nature 444, 364-368 (2006).
79. Surani MA, Hayashi K, Hajkova P: Genetic and epigenetic regulators of pluripotency. Cell 128, 747-762 (2007).
80. Kim J, Chu J, Shen X et al.: An extended network for pluripotency of embryonic stem cells. Cell 132, 1049-1061 (2008).
81. Jaenisch R, Young R: Stem cells, the molecular circuitry of pluripotency and nuclear reprogramming. Cell 132, 567-582 (2008).
82. Aoi T, Yae K, Nakagawa M et al.: Generation of pluripotent stem cells from adult mouse liver and stomach cells. Science 321, 699-702 (2008).
83. Yu J, Thomson JA: Pluripotent stem cell lines. Genes Dev. 22, 1987-1997 (2008).
84. Lunyak VV, Rosenfeld MG: Epigenetic regulation of stem cell fate. Hum. Mol. Genet. 17, R28-R36 (2008).
85. Singh SK, Kagalwala MN, Perker-Thornburg J et al.: REST maintains serf-renewal and pluripotency of embryonic stem cells. Nature. 453, 223-227 (2008).
86. Kagalwala MN, Singh SK, Majumder S: Stemness is only a state of the cell. Cold Spring Harb. Symp. Quant. Biol. (2009).
87. Kidder BL, Palmer S, Knott JG: Swi/SNF-Brg1 regulates self-renewal and occupies core pluripotency-related genes in embryonic stem cells. Stem Cells DOI: 10.1634/stemcells.2008-0710 (2008).
88. Houbaviy HB, Murray MF, Sharp PA: Embryonic stem cell specific microRNAs. Dev. Cell. 5, 351-358 (2003).
89. Canzonetta C, Mulligan C, Deutsch S et al.: DYRK1-A-dosage imbalance perturbs NRSF/REST levels, deregulating pluripotency and embryonic cell fate in Down syndrome. Am. J. Hum. Genet. 83, 388-400 (2008).
90. Kim MY, Jeong BC, Lee JH et al.: A repressor complex AP4, transcription factor and geminin, negatively regulates expression of target genes in nonneuronal cells. Proc. Natl Acad. Sci. USA 103, 13074-13079 (2006).
91. Carter MG, Stagg CA, Falco G et al.: An in situ hybridization-based screen for heterogeneously expressed genes in mouse ES cells. Gene Expr. Patterns 8, 181-198 (2008).
92. Bahn S, Mimmack M, Ryan M et al.: Neuronal target genes of the neuron restrictive silencer factor in neurospheres derived from fetuses with Down syndrome: a gene expression study. Lancet 359, 310-315 (2002).
93. Sohn SY, Weitzdoerfer R, Mori N, Lubeg G: Transcription factor REST-dependent proteins are comparable between Down syndrome and normal brains: challenging a hypothesis. J. Neural Transm. Suppl. 67, 59-66 (2003).
94. Leone S, Mutti C, Kazantsev A et al.: SAR and QSAR study on 2-aminothiazole derivatives, modulators of transcriptional repression in Huntington's disease. Bioorg. Med. Chem. 16, 5695-5703 (2008).